Effects of chloroquine in hematoporphyrin-treated animals

Chemico-Biological Interactions

Volumn 102, Issue 2, 1996, Pages 69-78

  Egger, Norman G ^a   Goeger, Douglas E ^a   Anderson, Karl E ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Chloroquine; Hematoporphyrin; Photodynamic therapy; Porphyria; Porphyrins

Indexed keywords

CHLOROQUINE; HEMATOPORPHYRIN; PORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHICK EMBRYO; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG FECES LEVEL; DRUG TISSUE LEVEL; DRUG URINE LEVEL; EMBRYO; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; RAT; SPECTROFLUOROMETRY; SPLEEN;

ANIMALS; CHICK EMBRYO; CHLOROQUINE; FEMALE; HEMATOPORPHYRINS; INJECTIONS, INTRAPERITONEAL; KIDNEY; LIVER; MALE; MICE; PORPHYRINS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SPLEEN;

ANIMALIA;

EID: 0030597040     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(96)03732-5     Document Type: Article

References (16)

1. [1] T.J. Dougherty and S.L. Marcus, Photodynamic Therapy, Eur. J. Cancer, 28A (1992) 1734-1742.
2. [2] H.I. Pass, Photodynamic therapy in oncology - mechanisms and clinical use, J. Natl. Cancer Inst., 85 (1993) 443-456.
3. [3] R.E. Ashton, J.L.M. Hawk and I.A. Magnus, Low-dose oral chloroquine in the treatment of porphyria cutanea tarda, Br. J. Dermatol., 3 (1984) 609-613.
4. [4] B.F. Felsher and A.G. Redeker, Effect of chloroquine on hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda, Medicine, 45 (1966) 575-583.
5. [5] J.J.F. Taljaard, B.C. Shanley, E.G. Stewart-Wynne, W.M. Deppe and S.M. Joubert, Studies on low dose chloroquine therapy and the action of chloroquine in symptomatic porphyria, Br. J. Derm., 87, (1972) 261-269.
6. [6] S.N. Cohen, K.O. Phifer and K.L. Yielding, Complex formation between chloroquine and ferrihaemic acid in vitro, and its effect on the antimalarial action of chloroquine, Nature, 202 (1964) 805-806.
7. [7] P.L. Scholnick, J. Epstein and H.S. Marver, The molecular basis of the action of chloroquine in porphyria cutanea tarda, J. Invest. Dermatol., 61 (1973) 226-232.
8. [8] H.S. Banyal and C.D. Fitch, Ferriprotoporphyrin in binding substances and the mode of action of chloroquine against malaria, Life Sci. 31 (1982) 1141-1144.
9. [9] D.E. Goeger and K.E. Anderson, Coumarin-induced changes in δ-aminolaevulinic acid synthase and cytochrome P-450 in chick embryo liver, Food Chem. Toxicol., 29 (1991) 145-151.
10. [10] K.E. Anderson, Effects of antihypertensive drugs on hepatic heme biosynthesis, and evaluation of ferrochelatase inhibitors to simplify testing of drugs for heme pathway induction, Biochim. Biophys. Acta 543 (1978) 313-327.
11. [11] W.H. Lockwood, V. Poulos, E. Rossi and D.H. Curnow, Rapid procedure for fecal porphyrin assay, Clin. Chem., 31 (1985) 1163-1167.
12. [12] S. Schwartz, P. Edmondson, B. Stephenson, D. Sarkar and H. Freyholtz, Direct spectrofluorophotometric determination of porphyrin in diluted urine, Ann. Clin. Res., 8 (1976) 156-161.
13. [13] C.K. Lim and T.J. Peters, Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias, Clin. Chim. Acta, 139 (1984) 55-63.
14. [14] E.W. Gunter, W.E. Turner and D.L. Huff, Investigation of protoporphyrin IX standard materials used in acid-extraction methods, and a proposed correction for the millimolar absorptivity of protoporphyrin IX, Clin. Chem., 35 (1989) 1601-1608.
15. [15] G. Goerz, K. Bolsen and H. Merk, Influence of chloroquine on the porphyrin metabolism, Arch. Dermatol. Res., 277 (1985) 114-117.
16. [16] N.G. Egger, D.E. Goeger and K.E. Anderson, Mobilization of porphyrins by chloroquine after hematoporphyrin administration, Hepatology, 20(4) (1994) 345A (A995).